Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients

Flavio A Cadegiani,1 Osvalmir Sá Silva2 1Division of Endocrinology and Metabolism, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, 2Corpometria Institute, an Obesity and Endocrinology Center, Brasilia, DF, Brazil...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cadegiani FA, Silva OS
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/5e483b0d35a044b0860d7968be7d559f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5e483b0d35a044b0860d7968be7d559f
record_format dspace
spelling oai:doaj.org-article:5e483b0d35a044b0860d7968be7d559f2021-12-02T01:07:19ZAcarbose promotes remission of both early and late dumping syndromes in post-bariatric patients1178-7007https://doaj.org/article/5e483b0d35a044b0860d7968be7d559f2016-12-01T00:00:00Zhttps://www.dovepress.com/acarbose-promotes-remission-of-both-early-and-late-dumping-syndromes-i-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Flavio A Cadegiani,1 Osvalmir Sá Silva2 1Division of Endocrinology and Metabolism, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, 2Corpometria Institute, an Obesity and Endocrinology Center, Brasilia, DF, Brazil Objective: Acarbose is a glucosidase inhibitor that slows carbohydrate digestion. It could thus be effective to promote remission of dumping syndrome (DS). Previous studies associating acarbose and late dumping, although not early dumping, have been reported. Herein, we aimed to evaluate the role of acarbose in dumping syndrome prevention and treatment and in resistive exercises resistance in bariatric subjects. Methods: Bariatric patients with DS and complete adherence to diet plan and resistive exercises were included (n=25). Number of early and late episodes, self-referred intensity of each episode, and ability to increase intensity of resistive exercise were evaluated, on a 0–10 scale. Acarbose was administered orally (50 mg) for 6 months, 4–5 times a day before meals. Results: Acarbose administration was associated with a decrease in the number of early (2.18–0.31) and late (2.79–0.12) episodes per week and intensity of each episode (6.10–1.65) and an increase in the ability to perform resistive exercises (3.03–7.12). Complete remission of DS was seen in 21 patients (84%), which persisted for 6 months with the use of acarbose. Conclusion: Acarbose prevented dumping in almost all studied subjects and helped improve exercise capacity. Keywords: dumping syndrome, bariatric surgery, post-bariatric, obesityCadegiani FASilva OSDove Medical PressarticleDumping SyndromeBariatric SurgeryPost-bariatricObesitySpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 9, Pp 443-446 (2016)
institution DOAJ
collection DOAJ
language EN
topic Dumping Syndrome
Bariatric Surgery
Post-bariatric
Obesity
Specialties of internal medicine
RC581-951
spellingShingle Dumping Syndrome
Bariatric Surgery
Post-bariatric
Obesity
Specialties of internal medicine
RC581-951
Cadegiani FA
Silva OS
Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients
description Flavio A Cadegiani,1 Osvalmir Sá Silva2 1Division of Endocrinology and Metabolism, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, 2Corpometria Institute, an Obesity and Endocrinology Center, Brasilia, DF, Brazil Objective: Acarbose is a glucosidase inhibitor that slows carbohydrate digestion. It could thus be effective to promote remission of dumping syndrome (DS). Previous studies associating acarbose and late dumping, although not early dumping, have been reported. Herein, we aimed to evaluate the role of acarbose in dumping syndrome prevention and treatment and in resistive exercises resistance in bariatric subjects. Methods: Bariatric patients with DS and complete adherence to diet plan and resistive exercises were included (n=25). Number of early and late episodes, self-referred intensity of each episode, and ability to increase intensity of resistive exercise were evaluated, on a 0–10 scale. Acarbose was administered orally (50 mg) for 6 months, 4–5 times a day before meals. Results: Acarbose administration was associated with a decrease in the number of early (2.18–0.31) and late (2.79–0.12) episodes per week and intensity of each episode (6.10–1.65) and an increase in the ability to perform resistive exercises (3.03–7.12). Complete remission of DS was seen in 21 patients (84%), which persisted for 6 months with the use of acarbose. Conclusion: Acarbose prevented dumping in almost all studied subjects and helped improve exercise capacity. Keywords: dumping syndrome, bariatric surgery, post-bariatric, obesity
format article
author Cadegiani FA
Silva OS
author_facet Cadegiani FA
Silva OS
author_sort Cadegiani FA
title Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients
title_short Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients
title_full Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients
title_fullStr Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients
title_full_unstemmed Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients
title_sort acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/5e483b0d35a044b0860d7968be7d559f
work_keys_str_mv AT cadegianifa acarbosepromotesremissionofbothearlyandlatedumpingsyndromesinpostbariatricpatients
AT silvaos acarbosepromotesremissionofbothearlyandlatedumpingsyndromesinpostbariatricpatients
_version_ 1718403319215423488